• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌患者外周血中细胞毒性 T 淋巴细胞相关蛋白 4 和叉头框 P3 转录本的上调。

Upregulation of Cytotoxic T-Lymphocyte-Associated Protein 4 and Forkhead Box P3 Transcripts in Peripheral Blood of Patients with Bladder Cancer.

机构信息

Department of Urology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

出版信息

Iran J Med Sci. 2021 Sep;46(5):339-346. doi: 10.30476/ijms.2020.84462.1426.

DOI:10.30476/ijms.2020.84462.1426
PMID:34539008
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8438340/
Abstract

BACKGROUND

Regulatory T cells (Tregs) play a key role in the progression of tumors. These cells express forkhead box P3 (FOXP3) and cytotoxic T-lymphocyte-associated protein 4 (CTLA4), which are the potential targets for cancer immunotherapy. The present study aimed to evaluate and transcripts in patients with bladder cancer (BC) compared with healthy individuals.

METHODS

Transcripts of and genes in the peripheral blood mononuclear cells (PBMCs) of 50 patients with histologically confirmed BC and 50 healthy individuals were assessed at the Institute for Cancer Research, Shiraz University of Medical Sciences (Shiraz, Iran) during 2014-2016. RNA was extracted from PBMCs, then cDNA was synthesized and subjected to quantitative real-time PCR (qRT-PCR) using appropriate primers. Statistical analysis was performed using SPSS software (version 21.0).

RESULTS

Significantly higher amounts of and gene transcripts were found in the peripheral blood of BC patients compared with healthy individuals. The expression of both genes was significantly higher in patients with non-invasive and grade I/II BC. The median of and transcript expressions was 3.74 and 5.39, respectively, in non-invasive BC patients, which was significant compared with the control group (P=0.0016 and P=0.009, respectively). The median of target gene mRNA expression in grade I/II BC patients was 2.9 for and 6.61 for , which was significant compared with the controls (P=0.013 and P=0.0037, respectively).

CONCLUSION

This study highlights the functional activity of Tregs in early stages of bladder cancer and showed the importance of CTLA4 and FOXP3, when it comes to screening BC.

摘要

背景

调节性 T 细胞(Tregs)在肿瘤的进展中起着关键作用。这些细胞表达叉头框 P3(FOXP3)和细胞毒性 T 淋巴细胞相关蛋白 4(CTLA4),它们是癌症免疫治疗的潜在靶点。本研究旨在评估与健康个体相比,膀胱癌(BC)患者外周血单个核细胞(PBMCs)中 和 转录本的表达情况。

方法

2014 年至 2016 年期间,在伊朗 Shiraz 大学医学科学研究所(Shiraz),评估了 50 例经组织学证实的 BC 患者和 50 例健康个体的 PBMCs 中 和 基因的转录本。从 PBMCs 中提取 RNA,然后使用适当的引物合成 cDNA 并进行定量实时 PCR(qRT-PCR)。使用 SPSS 软件(版本 21.0)进行统计学分析。

结果

与健康个体相比,BC 患者外周血中 和 基因转录本的含量明显更高。非浸润性和 I/II 级 BC 患者的两种基因表达均显著升高。非浸润性 BC 患者的 和 转录本表达中位数分别为 3.74 和 5.39,与对照组相比差异有统计学意义(P=0.0016 和 P=0.009)。I/II 级 BC 患者靶基因 mRNA 表达的中位数分别为 2.9 用于 和 6.61 用于 ,与对照组相比差异有统计学意义(P=0.013 和 P=0.0037)。

结论

本研究强调了 Tregs 在膀胱癌早期阶段的功能活性,并表明 CTLA4 和 FOXP3 在膀胱癌筛查中具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/902c/8438340/fdc1eda37c1e/IJMS-46-339-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/902c/8438340/f01455518921/IJMS-46-339-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/902c/8438340/28d5b817f56d/IJMS-46-339-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/902c/8438340/fdc1eda37c1e/IJMS-46-339-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/902c/8438340/f01455518921/IJMS-46-339-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/902c/8438340/28d5b817f56d/IJMS-46-339-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/902c/8438340/fdc1eda37c1e/IJMS-46-339-g003.jpg

相似文献

1
Upregulation of Cytotoxic T-Lymphocyte-Associated Protein 4 and Forkhead Box P3 Transcripts in Peripheral Blood of Patients with Bladder Cancer.膀胱癌患者外周血中细胞毒性 T 淋巴细胞相关蛋白 4 和叉头框 P3 转录本的上调。
Iran J Med Sci. 2021 Sep;46(5):339-346. doi: 10.30476/ijms.2020.84462.1426.
2
Increased CTLA-4 and FOXP3 transcripts in peripheral blood mononuclear cells of patients with breast cancer.乳腺癌患者外周血单个核细胞中 CTLA-4 和 FOXP3 转录本的增加。
Pathol Oncol Res. 2010 Dec;16(4):547-51. doi: 10.1007/s12253-010-9256-8. Epub 2010 Mar 21.
3
Association Between IL-17A, FOXP3, and CTLA4 Genes Expression and Severity of Lupus Nephritis.白细胞介素-17A、叉头框蛋白 P3 和细胞毒性 T 淋巴细胞相关蛋白 4 基因表达与狼疮肾炎严重程度的关系。
Iran J Kidney Dis. 2022 Jan;1(1):13-23.
4
Cytotoxic T lymphocyte antigen 4 (CTLA4) gene polymorphism with bladder cancer risk in North Indian population.北印度人群中细胞毒性T淋巴细胞抗原4(CTLA4)基因多态性与膀胱癌风险的关系
Mol Biol Rep. 2014 Feb;41(2):799-807. doi: 10.1007/s11033-013-2919-2. Epub 2014 Jan 4.
5
Overexpression of Regulatory T Cell-Related Markers (FOXP3, CTLA-4 and GITR) by Peripheral Blood Mononuclear Cells from Patients with Breast Cancer.乳腺癌患者外周血单个核细胞中调节性T细胞相关标志物(FOXP3、CTLA-4和GITR)的过表达
Asian Pac J Cancer Prev. 2018 Nov 28;19(11):3019-3025. doi: 10.31557/APJCP.2018.19.11.3019.
6
A Phenotypic Screening Approach Using Human Treg Cells Identified Regulators of Forkhead Box p3 Expression.一种使用人调节性 T 细胞进行表型筛选的方法鉴定了叉头框蛋白 p3 表达的调控因子。
ACS Chem Biol. 2019 Mar 15;14(3):543-553. doi: 10.1021/acschembio.9b00075. Epub 2019 Mar 4.
7
Evaluation of 1,25(OH)2D3 Effects on FOXP3, ROR-γt, GITR, and CTLA-4 Gene Expression in the PBMCs of Vitamin D-Deficient Women with Unexplained Recurrent Pregnancy Loss (URPL).评估维生素 D 缺乏的不明原因复发性妊娠丢失(URPL)妇女 PBMCs 中 FOXP3、ROR-γt、GITR 和 CTLA-4 基因表达受 1,25(OH)2D3 的影响。
Iran Biomed J. 2020 Sep;24(5):295-305. doi: 10.29252/ibj.24.5.290. Epub 2020 Feb 23.
8
Decreased CTLA4(+) and Foxp3(+) CD25(high)CD4(+) cells in induced sputum from patients with mild atopic asthma.轻度特应性哮喘患者诱导痰中 CTLA4(+)和 Foxp3(+) CD25(high) CD4(+)细胞减少。
Allergol Int. 2013 Jun;62(2):203-13. doi: 10.2332/allergolint.12-OA-0492. Epub 2013 Mar 25.
9
Frequency and expression of inhibitory markers of CD4(+) CD25(+) FOXP3(+) regulatory T cells in patients with common variable immunodeficiency.常见可变免疫缺陷患者中 CD4(+) CD25(+) FOXP3(+) 调节性 T 细胞抑制性标记物的频率和表达。
Scand J Immunol. 2013 May;77(5):405-12. doi: 10.1111/sji.12040.
10
Low expressions of PD-L1 and CTLA-4 by induced CD4CD25 Foxp3 Tregs in patients with SLE and their correlation with the disease activity.SLE 患者诱导的 CD4CD25 Foxp3 Treg 细胞中 PD-L1 和 CTLA-4 的低表达及其与疾病活动的相关性。
Cytokine. 2020 Sep;133:155119. doi: 10.1016/j.cyto.2020.155119. Epub 2020 Jun 11.

引用本文的文献

1
From Bench to Bladder: The Rise in Immune Checkpoint Inhibition in the Treatment of Non-Muscle Invasive Bladder Cancer.从实验室到临床应用:免疫检查点抑制剂在非肌层浸润性膀胱癌治疗中的兴起
Cancers (Basel). 2025 Mar 28;17(7):1135. doi: 10.3390/cancers17071135.

本文引用的文献

1
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3 Regulatory T Cells (Tregs) in Human Cancers-Letter.抗CTLA-4免疫疗法不会耗竭人类癌症中的FOXP3调节性T细胞(Tregs)——信函
Clin Cancer Res. 2019 Jun 1;25(11):3468. doi: 10.1158/1078-0432.CCR-18-3740. Epub 2018 Dec 4.
2
Urinary Markers in Bladder Cancer: An Update.膀胱癌中的尿液标志物:最新进展
Front Oncol. 2018 Sep 7;8:362. doi: 10.3389/fonc.2018.00362. eCollection 2018.
3
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3 Regulatory T Cells (Tregs) in Human Cancers.抗 CTLA-4 免疫疗法不会耗尽人类癌症中的 FOXP3+调节性 T 细胞(Tregs)。
Clin Cancer Res. 2019 Feb 15;25(4):1233-1238. doi: 10.1158/1078-0432.CCR-18-0762. Epub 2018 Jul 27.
4
Clinical Implication of MicroRNAs in Molecular Pathology: An Update for 2018.微小RNA在分子病理学中的临床意义:2018年最新进展
Clin Lab Med. 2018 Jun;38(2):237-251. doi: 10.1016/j.cll.2018.02.003.
5
Urinary Bladder Cancer Tregs Suppress MMP2 and Potentially Regulate Invasiveness.膀胱癌调节性 T 细胞抑制 MMP2 并可能调节侵袭性。
Cancer Immunol Res. 2018 May;6(5):528-538. doi: 10.1158/2326-6066.CIR-17-0466. Epub 2018 Mar 27.
6
Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.通过分析驱动基因突变和非整倍体进行尿路上皮癌的无创检测。
Elife. 2018 Mar 20;7:e32143. doi: 10.7554/eLife.32143.
7
Detection and localization of surgically resectable cancers with a multi-analyte blood test.通过多分析物血液检测对外科可切除癌症进行检测和定位。
Science. 2018 Feb 23;359(6378):926-930. doi: 10.1126/science.aar3247. Epub 2018 Jan 18.
8
Expression of N-Myc Downstream-Regulated Gene 2 in Bladder Cancer and Its Potential Utility as a Urinary Diagnostic Biomarker.N-Myc 下游调节基因 2 在膀胱癌中的表达及其作为尿液诊断生物标志物的潜在应用。
Med Sci Monit. 2017 Sep 27;23:4644-4649. doi: 10.12659/msm.901610.
9
Interleukin-27 augments the inhibitory effects of sorafenib on bladder cancer cells.白细胞介素-27增强索拉非尼对膀胱癌细胞的抑制作用。
Braz J Med Biol Res. 2017 Jul 20;50(8):e6207. doi: 10.1590/1414-431X20176207.
10
Urinary transcript quantitation of CK20 and IGF2 for the non-invasive bladder cancer detection.用于非侵入性膀胱癌检测的CK20和IGF2的尿液转录本定量分析。
J Cancer Res Clin Oncol. 2017 Sep;143(9):1757-1769. doi: 10.1007/s00432-017-2433-3. Epub 2017 May 8.